Antisense oligonucleotides (ASOs), specialised molecules that may regulate RNA and affect protein creation, are being injected directly into the cerebrospinal fluid, the region around the brain and spinal cord, as a prospective treatment for a variety of brain illnesses.
According to new research, testing for genetic abnormalities in urine can identify bladder cancer years before the disease manifests clinical symptoms.
In a historic moment, the Indian Institute of Technology (IIT) Kanpur has licensed a pioneering technology to Reliance Life Sciences Pvt Ltd that has the potential to revolutionize the field of gene therapy, especially for many genetic eye diseases. There are many inherited disorders caus
According to new research, a peptide (small protein) called PEPITEM could provide a game-changing approach to lowering the risk of type 2 diabetes and other obesity-related diseases like hepatic steatosis (fatty liver).
Adding evidence to the importance of early development, a new study links neutral maternal behaviour toward infants with an epigenetic change in children related to the stress response.
Globally, an estimated 8 million newborns are born with a birth defect every year. Nine out of every ten children born with a serious birth defect are in low- and middle-income countries. The most common severe birth defects are heart defects, neural tube defects and Down syndrome, but there
A genetic variant of autism and schizophrenia that causes social deficits and seizures in mice and people has been linked to a cause, according to researchers from Northwestern Medicine.
Uttar Pradesh [India], February 28 (ANI/NewsVoir): Asia's largest emergency medical service provider company Ziqitza Healthcare Limited after having achieved major milestones in the country by providing ambulances and medical helplines in multiple states of India is now all set to step into
One in every 5,000 boys born suffers from the crippling muscle-wasting illness DMD, which is known to be caused by mutations of the dystrophin gene. Typically, those who have the illness only survive into their 20s or 30s.
Women who have BRCA1 or BRCA2 genetic abnormalities continue to have a significant chance of developing cancer after age 50, even if they have never been diagnosed with the disease. This is true even though these mutations are linked to a younger beginning of breast and ovarian cancer
According to a study, when scientists transformed a single regulatory gene in a sea anemone species, a stinging cell that normally shoots a venomous miniature harpoon for hunting and self-defence switched to shooting a sticky thread that entangles prey.